[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Global & China Secondary Progressive Multiple Sclerosis Drug Market Research by Company, Type & Application 2015-2026

August 2021 | 97 pages | ID: C47A5EEB9B49EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

HeyReport estimates that the Secondary Progressive Multiple Sclerosis Drug market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.

In this report, HeyReport discusses the Global & China industrial policies, economic environment, and the impact of covid-19 on the Secondary Progressive Multiple Sclerosis Drugindustry and its cost structure. Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.

Market Segment as follows:

Product Type Segmentation Includes
  • Inebilizumab
  • GLX-1112
  • DC-TAB
  • Etomoxir
  • IB-MS
  • Others
Application Segmentation Includes
  • Hospital
  • Clinic
  • Others
Companies Includes
  • AB Science SA
  • Actelion Ltd
  • Biogen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genzyme Corporation
  • Glialogix, Inc.
  • Immune Response BioPharma, Inc.
  • Innate Immunotherapeutics Ltd
  • Kyorin Pharmaceutical Co., Ltd.
  • Mallinckrodt Plc
  • MedDay SA
  • MedImmune, LLC
  • Merck KGaA
  • Meta-IQ ApS
  • Novartis AG
  • Opexa Therapeutics, Inc.
  • Xenetic Biosciences (UK) Limited
The main contents of the report including:

Section 1:
Product definition, type and application, Global & China market overview;
Section 2:
Global & China Market competition by company;
Section 3:
Global & China sales revenue, volume and price by type;
Section 4:
Global & China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
Industrial policies & economic environment
Section 9:
Conclusion.
For any other requirements, please feel free to contact HeyReport for customized contents.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Inebilizumab
    1.1.2.2 GLX-1112
    1.1.2.3 DC-TAB
    1.1.2.4 Etomoxir
    1.1.2.5 IB-MS
    1.1.2.6 Others
  1.1.3 Market by Application
    1.1.3.1 Hospital
    1.1.3.2 Clinic
    1.1.3.3 Others
1.2 Global & China Market Size & Forecast
  1.2.1 Global Market (2015-2020 & 2021-2026)
  1.2.2 China Market (2015-2020 & 2021-2026)

2 GLOBAL & CHINA MARKET BY COMPANY

2.1 Global Sales by Company
2.2 China Sales by Company

3 GLOBAL & CHINA MARKET BY TYPE

3.1 Global Sales by Product Type
3.2 China Sales by Product Type

4 GLOBAL & CHINA MARKET BY APPLICATION

4.1 Global Sales by Application
4.2 China Sales by Application

5 CHINA TRADE

5.1 Export Overview
5.2 Import Overview

6 KEY COMPANIES LIST

6.1 AB Science SA
  6.1.1 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Actelion Ltd
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Biogen, Inc.
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 F. Hoffmann-La Roche Ltd.
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Genzyme Corporation
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Glialogix, Inc.
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Immune Response BioPharma, Inc.
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Innate Immunotherapeutics Ltd
  6.8.1 Company Information
  6.8.2 Product Specifications
  6.8.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Kyorin Pharmaceutical Co., Ltd.
  6.9.1 Company Information
  6.9.2 Product Specifications
  6.9.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Mallinckrodt Plc
  6.10.1 Company Information
  6.10.2 Product Specifications
  6.10.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 MedDay SA
  6.11.1 Company Information
  6.11.2 Product Specifications
  6.11.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.12 MedImmune, LLC
  6.12.1 Company Information
  6.12.2 Product Specifications
  6.12.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.13 Merck KGaA
  6.13.1 Company Information
  6.13.2 Product Specifications
  6.13.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.14 Meta-IQ ApS
  6.14.1 Company Information
  6.14.2 Product Specifications
  6.14.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.15 Novartis AG
  6.15.1 Company Information
  6.15.2 Product Specifications
  6.15.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.16 Opexa Therapeutics, Inc.
  6.16.1 Company Information
  6.16.2 Product Specifications
  6.16.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.17 Xenetic Biosciences (UK) Limited
  6.17.1 Company Information
  6.17.2 Product Specifications
  6.17.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Upstream Overview

8 POLICIES & MARKET ENVIRONMENT

8.1 Policies
  8.1.1 Major Regions Policies
  8.1.2 Policies in China
8.2 Market Environment
  8.2.1 Porter's Five Forces
  8.2.2 Impact of COVID-19

9 RESEARCH CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2015-2020
Table Global Market Sales Revenue Share by Company 2015-2020
Table Global Market Sales Volume by Company 2015-2020
Table Global Market Sales Volume Share by Company 2015-2020
Table Global Price by Company 2015-2020
Table China Market Sales Revenue by Company 2015-2020
Table China Market Sales Revenue Share by Company 2015-2020
Table China Market Sales Volume by Company 2015-2020
Table China Market Sales Volume Share by Company 2015-2020
Table China Price by Company 2015-2020
Table Global Market Sales Revenue by Type 2015-2020
Table Global Market Sales Revenue Share by Type 2015-2020
Table Global Market Sales Volume by Type 2015-2020
Table Global Market Sales Volume Share by Type 2015-2020
Table Global Price by Type 2015-2020
Table China Market Sales Revenue by Type 2015-2020
Table China Market Sales Revenue Share by Type 2015-2020
Table China Market Sales Volume by Type 2015-2020
Table China Market Sales Volume Share by Type 2015-2020
Table China Price by Type 2015-2020
Table Global Market Sales Revenue by Application 2015-2020
Table Global Market Sales Revenue Share by Application 2015-2020
Table Global Market Sales Volume by Application 2015-2020
Table Global Market Sales Volume Share by Application 2015-2020
Table Global Price by Application 2015-2020
Table China Market Sales Revenue by Application 2015-2020
Table China Market Sales Revenue Share by Application 2015-2020
Table China Market Sales Volume by Application 2015-2020
Table China Market Sales Volume Share by Application 2015-2020
Table China Price by Application 2015-2020
Table China Export 2015-2020 (Million USD)
Table China Export 2015-2020 (Volume)
Table China Import 2015-2020 (Million USD)
Table China Import 2015-2020 (Volume)
Table Sales Revenue, Salels Volume, Price, Cost and Margin of AB Science SA 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Actelion Ltd 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Biogen, Inc. 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd. 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Genzyme Corporation 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Glialogix, Inc. 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Immune Response BioPharma, Inc. 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Innate Immunotherapeutics Ltd 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Kyorin Pharmaceutical Co., Ltd. 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Mallinckrodt Plc 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of MedDay SA 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of MedImmune, LLC 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Merck KGaA 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Meta-IQ ApS 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Novartis AG 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Opexa Therapeutics, Inc. 
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Xenetic Biosciences (UK) Limited


LIST OF FIGURES

Figure Inebilizumab  Market Size and Growth 2015-2020 (Million USD)
Figure Inebilizumab  Market Size and Growth 2015-2020 (Volume)
Figure Inebilizumab  Market Forecast and Growth 2021-2026 (Million USD)
Figure Inebilizumab  Market Forecast and Growth 2021-2026 (Volume)
Figure GLX-1112  Market Size and Growth 2015-2020 (Million USD)
Figure GLX-1112  Market Size and Growth 2015-2020 (Volume)
Figure GLX-1112  Market Forecast and Growth 2021-2026 (Million USD)
Figure GLX-1112  Market Forecast and Growth 2021-2026 (Volume)
Figure DC-TAB  Market Size and Growth 2015-2020 (Million USD)
Figure DC-TAB  Market Size and Growth 2015-2020 (Volume)
Figure DC-TAB  Market Forecast and Growth 2021-2026 (Million USD)
Figure DC-TAB  Market Forecast and Growth 2021-2026 (Volume)
Figure Etomoxir  Market Size and Growth 2015-2020 (Million USD)
Figure Etomoxir  Market Size and Growth 2015-2020 (Volume)
Figure Etomoxir  Market Forecast and Growth 2021-2026 (Million USD)
Figure Etomoxir  Market Forecast and Growth 2021-2026 (Volume)
Figure IB-MS  Market Size and Growth 2015-2020 (Million USD)
Figure IB-MS  Market Size and Growth 2015-2020 (Volume)
Figure IB-MS  Market Forecast and Growth 2021-2026 (Million USD)
Figure IB-MS  Market Forecast and Growth 2021-2026 (Volume)
Figure Others Market Size and Growth 2015-2020 (Million USD)
Figure Others Market Size and Growth 2015-2020 (Volume)
Figure Others Market Forecast and Growth 2021-2026 (Million USD)
Figure Others Market Forecast and Growth 2021-2026 (Volume)
Figure Hospital  Market Size and Growth 2015-2020 (Million USD)
Figure Hospital  Market Size and Growth 2015-2020 (Volume)
Figure Hospital  Market Forecast and Growth 2021-2026 (Million USD)
Figure Hospital  Market Forecast and Growth 2021-2026 (Volume)
Figure Clinic  Market Size and Growth 2015-2020 (Million USD)
Figure Clinic  Market Size and Growth 2015-2020 (Volume)
Figure Clinic  Market Forecast and Growth 2021-2026 (Million USD)
Figure Clinic  Market Forecast and Growth 2021-2026 (Volume)
Figure Others Market Size and Growth 2015-2020 (Million USD)
Figure Others Market Size and Growth 2015-2020 (Volume)
Figure Others Market Forecast and Growth 2021-2026 (Million USD)
Figure Others Market Forecast and Growth 2021-2026 (Volume)
Figure Global Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2015-2020 (Million USD)
Figure Global Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2015-2020 (Volume)
Figure Global Secondary Progressive Multiple Sclerosis Drug Market Forecast and Growth 2021-2026 (Million USD)
Figure Global Secondary Progressive Multiple Sclerosis Drug Market Forecast and Growth 2021-2026 (Volume)
Figure China Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2015-2020 (Million USD)
Figure China Secondary Progressive Multiple Sclerosis Drug Market Size and Growth 2015-2020 (Volume)
Figure China Secondary Progressive Multiple Sclerosis Drug Market Forecast and Growth 2021-2026 (Million USD)
Figure China Secondary Progressive Multiple Sclerosis Drug Market Forecast and Growth 2021-2026 (Volume)
Figure Global Market Sales Revenue Share by Company in 2019
Figure Global Market Sales Volume Share by Company in 2019
Figure China Market Sales Revenue Share by Company in 2019
Figure China Market Sales Volume Share by Company in 2019
Figure Global Market Sales Revenue Share by Type in 2019
Figure Global Market Sales Volume Share by Type in 2019
Figure China Market Sales Revenue Share by Type in 2019
Figure China Market Sales Volume Share by Type in 2019
Figure Global Market Sales Revenue Share by Application in 2019
Figure Global Market Sales Volume Share by Application in 2019
Figure China Market Sales Revenue Share by Application in 2019
Figure China Market Sales Volume Share by Application in 2019
Figure Industry Chain Overview


More Publications